Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients

Current Medical Research and Opinion
D CzarneckaU Gottwald-Hostalek

Abstract

The study objective was assessing patient adherence to a fixed-dose combination (FDC) of bisoprolol and amlodipine in daily practice in patients who had been switched from the free to the fixed-dose combination prior to recruitment. The non-investigational study was carried out in Poland. Patients over 18 years of age with essential hypertension were recruited if they had already been switched from a free combination to the FDC at least 4 weeks prior to recruitment. Exclusion criteria included pregnancy, lactation, any contraindication to the FDC, and other antihypertensive treatment. Adherence was measured by tablet count (tablets taken divided by tablets prescribed, times 100) and defined as follows: excellent >90%, good 76-90%, moderate 51-75%, bad ≤50%. Other patient data, clinical findings and laboratory values were recorded upon availability at study start, after 3 months (voluntary) and after 6 months. Data of 4288 patients (mean age: 59 years; gender: 50% each) were documented. The average daily doses of the FDC were 5.8 mg bisoprolol and 6.4 mg amlodipine. These doses differ only slightly from those of the free combination. After 3 months' treatment with the FDC, a dose increase was carried out in 113 patients for biso...Continue Reading

References

Jul 8, 1991·Ugeskrift for laeger·O L Pedersen, P Schroeder
Nov 1, 1989·American Heart Journal·I Osterloh
Jun 18, 1999·Cardiovascular Drugs and Therapy·C Smith, M Teitler
Feb 19, 2000·Hypertension·R PedrinelliM Mariani
Jun 11, 2003·Journal of Clinical Pharmacy and Therapeutics·S L NuttallM J Kendall
Oct 20, 2009·Journal of Hypertension·Giuseppe ManciaUNKNOWN European Society of Hypertension
Feb 24, 2010·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Apr 9, 2010·Journal of the American Society of Hypertension : JASH·Alan H GradmanUNKNOWN American Society of Hypertension Writing Group

❮ Previous
Next ❯

Citations

Oct 27, 2016·Clinical Pharmacology in Drug Development·Ulrike Gottwald-HostalekSteven Hildemann
Feb 20, 2018·The Journal of Clinical Hypertension·Peter BramlageHelen Sims
Oct 27, 2018·Current Medical Research and Opinion·Li ShaoZhong-Min Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.